Sign In
Buy ALRN
$2.11
+0 (+0%)
At Close: Apr 09, 2025
Aileron Therapeutics to Present at the H.C. Wainwright Global Investment Conference
07:00am, Tuesday, 17'th May 2022
BOSTON, May 17, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patient
Aileron Therapeutics to Host Virtual KOL Investor Event on May 19, 2022
11:00am, Friday, 13'th May 2022 GlobeNewswire Inc.
BOSTON, May 13, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patie
Aileron Therapeutics Announces Late-Breaking Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at Upcoming Society for Investigative Dermatology 2022 Annual Meeting
04:43pm, Tuesday, 10'th May 2022 GlobeNewswire Inc.
BOSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patie
Aileron Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
08:15pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
BOSTON, May 05, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patie
Is Aileron Therapeutics (ALRN) Outperforming Other Medical Stocks This Year?
11:19am, Thursday, 21'st Apr 2022
Here is how Aileron Therapeutics, Inc. (ALRN) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
Is Aileron Therapeutics, Inc. (ALRN) Stock Outpacing Its Medical Peers This Year?
01:40pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Here is how Aileron Therapeutics, Inc. (ALRN) and Becton Dickinson (BDX) have performed compared to their sector so far this year.
Is Aileron Therapeutics, Inc. (ALRN) Stock Outpacing Its Medical Peers This Year?
11:18am, Tuesday, 05'th Apr 2022
Here is how Aileron Therapeutics, Inc. (ALRN) and Becton Dickinson (BDX) have performed compared to their sector so far this year.
Aileron Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights
08:20pm, Monday, 28'th Mar 2022 GlobeNewswire Inc.
BOSTON, Mass., March 28, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save m
Top Must-Watch Penny Stocks For Your April List
08:06pm, Friday, 25'th Mar 2022 PennyStocks
Are these penny stocks on your April watchlist?
The post Top Must-Watch Penny Stocks For Your April List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Aileron Therapeutics to Participate in Maxim Group 2022 Virtual Growth Conference
12:04pm, Tuesday, 22'nd Mar 2022 GlobeNewswire Inc.
BOSTON, March 22, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to develop medicines to make chemotherapy safer and thereby more effec
Aileron Therapeutics (ALRN) Investor Presentation - Slideshow
07:13pm, Tuesday, 11'th Jan 2022 Seeking Alpha
Aileron Therapeutics Provides Business Update and Outlines 2022 Strategic Priorities to Deliver Key Milestones
01:04pm, Wednesday, 05'th Jan 2022 GlobeNewswire Inc.
BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company that aspires to develop medicines to make chemotherapy safer and thereby more effecti
Aileron Therapeutics to Present at Upcoming Investor Conferences
01:45pm, Tuesday, 04'th Jan 2022 GlobeNewswire Inc.
BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer pati
Aileron Therapeutics to Present at Upcoming Investor Conferences
08:45am, Tuesday, 04'th Jan 2022
BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patien
Aileron Therapeutics Issues Statement on Passing of Scientific Advisory Board Member and Nobel Laureate Robert H. Grubbs
03:56pm, Monday, 20'th Dec 2021 GlobeNewswire Inc.
BOSTON, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN) today issued the following statement regarding the passing of Nobel Laureate Robert H. Grubbs, Ph.D., who served as a me
